Preface on Lung Cancer Diagnostics and Treatments 2015: A Renaissance of Patient Care1
Review Article on Lung Cancer Diagnostics and Treatments 2015: A Renaissance of Patient Care1
Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities
Evidence-Based Medicine2
Controversies on Lung Cancer: Pros and Cons (Section Chairs: Suresh Senan, Helmut H. Popper)3
Editorial
Letter to the Editor
Disclosure:
1. The series “Lung Cancer Diagnostics and Treatments 2015: A Renaissance of Patient Care” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Edward S. Kim served as the unpaid Guest Editor for the series.
2. The series “Evidence-Based Medicine” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
3. The series “Controversies on Lung Cancer: Pros and Cons” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Suresh Senan and Helmut H. Popper served as the unpaid Guest Editors for the series.